Nosopharm renews its partnership with Inra
This second screening campaign aims to discover new classes ofantimicrobial agents for treating multi-resistant infections
Lyon, France, May 30, 2018 – Nosopharm, a company dedicated to the research and development of new anti-infective drugs, today announces that it has renewed its partnership with the French National Institute of Agricultural Research (Inra). This partnership with Inra’s Diversity, Genomes and Insects-Microorganisms Interactions laboratory (DGIMI) aims to develop new classes of antimicrobial agents for treating multidrug resistant hospital-acquired infections. These new classes of antimicrobials will then be the subject of patent applications and scientific publications.